age
Item
male or female patients age 4 -6 years
boolean
C0001779 (UMLS CUI [1])
mild intermittent asthma
Item
diagnosis of mild intermittent bronchial asthma (step i-ii) in the past 6 - 12 months as stated by the investigator:
boolean
C1960045 (UMLS CUI [1])
inhaled beta-2-agonists
Item
use of inhaled beta-2-agonists < 1/week (max 3 puff /d)
boolean
C1373132 (UMLS CUI [1,1])
C0001559 (UMLS CUI [1,2])
exacerbation-free interval
Item
exacerbation-free interval > 4 weeks prior to visit 1
boolean
C0349790 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
written informed consent
Item
the written informed consent of parents after received written and oral information about the aim, purpose and risks of the study must be present
boolean
C0021430 (UMLS CUI [1])
asthma severity
Item
asthma severity ≥ step 2
boolean
C0581122 (UMLS CUI [1])
severe concomitant diseases
Item
severe concomitant diseases
boolean
C0009488 (UMLS CUI [1])
suspected non-compliance
Item
suspected non-compliance
boolean
C1321605 (UMLS CUI [1])
age
Item
age below 4 and age above 7 years
boolean
C0001779 (UMLS CUI [1])
last study participation
Item
last study participation < 30 days
boolean
C2348568 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])